Detalles de la búsqueda
1.
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer.
Oncologist
; 29(5): e681-e689, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241181
2.
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.
Cancer Sci
; 114(2): 606-618, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169649
3.
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.
Cancer Immunol Immunother
; 72(6): 1699-1707, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36617602
4.
Microbiological analysis of patients with first and recurrent episodes of acute cholangitis in a middle-sized hospital: A single-center retrospective study in rural North Kyoto, Japan.
J Infect Chemother
; 28(3): 413-419, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973874
5.
Study of factors related to recurrence within 30 days after pneumonia treatment for community-onset pneumonia.
J Infect Chemother
; 27(12): 1683-1688, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34483030
6.
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cancer
; 126(1): 219-227, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31503343
7.
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
Oncologist
; 25(12): e1869-e1878, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654250
8.
Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801.
Oncologist
; 25(8): e1146-e1157, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32385918
9.
Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital.
BMC Geriatr
; 19(1): 3, 2019 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30616612
10.
Sensitivity of epidermal growth factor receptor with single or double uncommon mutations to afatinib confirmed by a visual assay.
Cancer Sci
; 109(11): 3657-3661, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30255614
11.
Comprehensive analysis of prognostic factors in hospitalized patients with pneumonia occurring outside hospital: Serum albumin is not less important than pneumonia severity assessment scale.
J Infect Chemother
; 24(8): 602-609, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29628384
12.
Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma.
Cancer Sci
; 108(1): 116-123, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27783867
13.
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.
Cancer Sci
; 108(9): 1843-1849, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28667792
14.
Severe acute interstitial lung disease in a patient with anaplastic lymphoma kinase rearrangement-positive non-small cell lung cancer treated with alectinib.
Invest New Drugs
; 33(5): 1148-50, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26334220
15.
Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement.
Invest New Drugs
; 33(2): 510-2, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25433426
16.
Histological evolution of pleuroparenchymal fibroelastosis.
Histopathology
; 66(4): 545-54, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25234959
17.
Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer.
Biol Pharm Bull
; 38(8): 1192-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235582
18.
Intrathecal Trastuzumab for HER2-Positive Cancer of Unknown Primary Leptomeningeal Metastasis: A Case Report.
Cureus
; 16(3): e57322, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38690464
19.
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study).
Thorac Cancer
; 15(2): 163-171, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38013668
20.
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.
Front Immunol
; 15: 1348034, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38464519